Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidson, K. W.
Right arrow Articles by Suls, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidson, K. W.
Right arrow Articles by Suls, J. M.
Related Collections
Right arrow Depression
Right arrow Reviews
Right arrow Other Cardiovascular Medicine
Psychosomatic Medicine 68:645-650 (2006)
© 2006 American Psychosomatic Society


SPECIAL ARTICLE

Assessment and Treatment of Depression in Patients With Cardiovascular Disease: National Heart, Lung, and Blood Institute Working Group Report

Karina W. Davidson, PhD, David J. Kupfer, MD, J. Thomas Bigger, MD, Robert M. Califf, MD, Robert M. Carney, PhD, James C. Coyne, PhD, Susan M. Czajkowski, PhD, Ellen Frank, PhD, Nancy Frasure-Smith, PhD, Kenneth E. Freedland, PhD, Erika S. Froelicher, RN, PhD, Alexander H. Glassman, MD, Wayne J. Katon, MD, Peter G. Kaufmann, PhD, Ronald C. Kessler, PhD, Helena C. Kraemer, PhD, K. Ranga R. Krishnan, MD, François Lespérance, MD, Nina Rieckmann, PhD, David S. Sheps, MD, MSPH and Jerry M. Suls, PhD

From the Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY (K.W.W.1, J.T.B.,1 A.H.G.2); Cardiovascular Institute (K.W.W.1) and Department of Psychiatry (K.W.W.,1 N.R.1), Mount Sinai School of Medicine, New York, NY; Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA (D.J.K.,2 E.F.2); Behavioral Medicine and Prevention Research Group, National Heart, Lung, and Blood Institute, Bethesda, MD (S.M.C.,2 P.G.K.1); Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (R.M.C.2); Department of Psychiatry, Behavioral Medicine Center, Washington University School of Medicine, St. Louis, MO (R.M.C.,2 K.E.F.1); Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA (J.C.C.1); Department of Psychiatry and School of Nursing, McGill University, Montreal; the Montreal Heart Institute Research Center, Montreal; Centre Hospitalier de l'Universite de Montreal Research Center, Montreal; Department of Psychiatry, University of Montreal, Montreal, Quebec, Canada (N.F.-S.1); School of Nursing, University of California San Francisco, San Francisco, CA (E.S.F.2); Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA (W.J.K.2); Department of Health Care Policy, Harvard Medical School, Boston, MA (R.C.K.1); Department of Psychiatry and Behavioral Science, Stanford University, Stanford, CA (H.C.K.1); Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC (K.R.R.K.1); Department of Psychiatry, University of Montreal, Montréal, Quebec, Canada (F.L.2); Division of Cardiovascular Medicine, University of Florida, and Malcom Randall VA Medical Center, Gainesville, FL (D.S.S.2); Department of Psychology, University of Iowa, Iowa City, IA (J.M.S.1).

Address correspondence and reprint requests to Karina W. Davidson, PhD, Department of Medicine, Columbia University College of Physicians and Surgeons, 622 W 168th St, PH9 Center, Room 941, New York, NY 10032. E-mail: kd2124{at}columbia.edu

Objective: The National Heart, Lung, and Blood Institute convened an interdisciplinary working group of experts to develop recommendations for the assessment and treatment of depression in patients with coronary heart disease (CHD).

Method: Consensus of experts.

Results: Our current recommendations are that the Beck Depression Inventory-I be employed for epidemiological studies of depression and CHD, that the Patient Health Questionnaire 2-item version be employed for screening for trial eligibility, that the Depression Interview and Structured Hamilton (DISH) be employed for diagnostic ascertainment for trial inclusion, and that the Hamilton rating scale, which is part of the DISH, be employed for both depression symptom reduction and the remission criterion in any trial. We further recommend that a randomized controlled trial be undertaken to determine whether selective serotonin reuptake inhibitors, psychotherapy, or combined treatment can reduce the risk of CHD events and mortality associated with depression in CHD patients.

Conclusions: This report summarizes the recommendations made by the working group and discusses the rationale for each recommendation, the strengths and weaknesses of alternative approaches to assessment and treatment, and the implications for future research in this area.

Key Words: depression • cardiovascular diseases • assessment • treatment • consensus • recommendations

Abbreviations: ACS = acute coronary syndrome; BDI = Beck Depression Inventory; CBASP = Cognitive Behavioral Analysis System of Psychotherapy; CBT = cognitive behavior therapy; CIDI = Composite International Diagnostic Interview; CHD = coronary heart disease; CVD = cardiovascular disease; DISH = Depression Interview and Structured Hamilton; ENRICHD = Enhancing Recovery in Coronary Heart Disease; HAM-D = Hamilton Rating Scale for Depression; IDS-SR = Inventory of Depressive Symptomatology, self-report; IMPACT = Improving Mood–Promoting Access to Collaborative Treatment; IPT = interpersonal therapy; MI = myocardial infarction; NHLBI = National Heart, Lung, and Blood Institute; PHQ = Patient Health Questionnaire; RCT = randomized controlled trial; SADHART = Sertraline Antidepressant Heart Attack Randomized Trial; SCID = Structured Clinical Interview for DSM-IV; SSRI = selective serotonin reuptake inhibitor; STAR*D = Sequenced Treatment Alternatives to Relieve Depression.




This article has been cited by other articles:


Home page
Cleveland Clinic Journal of MedicineHome page
L. POZUELO, G. TESAR, J. ZHANG, M. PENN, K. FRANCO, and W. JIANG
Depression and heart disease: What do we know, and where are we headed?
Cleveland Clinic Journal of Medicine, January 1, 2009; 76(1): 59 - 70.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. D. Thombs, P. de Jonge, J. C. Coyne, M. A. Whooley, N. Frasure-Smith, A. J. Mitchell, M. Zuidersma, C. Eze-Nliam, B. B. Lima, C. G. Smith, et al.
Depression Screening and Patient Outcomes in Cardiovascular Care: A Systematic Review
JAMA, November 12, 2008; 300(18): 2161 - 2171.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
F. M. Yang and R. N. Jones
Measurement Differences in Depression: Chronic Health-Related and Sociodemographic Effects in Older Americans
Psychosom Med, November 1, 2008; 70(9): 993 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. R. Bhattacharyya, D. L. Whitehead, R. Rakhit, and A. Steptoe
Depressed Mood, Positive Affect, and Heart Rate Variability in Patients With Suspected Coronary Artery Disease
Psychosom Med, November 1, 2008; 70(9): 1020 - 1027.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
P. Walters, M. Ashworth, and A. Tylee
Ethnic density, physical illness, social deprivation and antidepressant prescribing in primary care: ecological study
The British Journal of Psychiatry, September 1, 2008; 193(3): 235 - 239.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
A. E. Von Ruden, D. E. Adson, and M. Kotlyar
Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Morbidity and Mortality
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2008; 13(1): 32 - 40.
[Abstract] [PDF]


Home page
Eur Heart JHome page
F. Dobbels
Does every cardiologist need a psychologist?
Eur. Heart J., December 2, 2007; 28(24): 2964 - 2966.
[Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. E. Dimsdale and R. Dantzer
A Biological Substrate for Somatoform Disorders: Importance of Pathophysiology
Psychosom Med, November 1, 2007; 69(9): 850 - 854.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Psychosomatic Society